Inovio Pharmaceuticals Inc. Stock Climbs 5.5%, Outperforms Peers

Dow Jones2026/10/09 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Inovio Pharmaceuticals Inc. rose 5.5% to $1.15 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 27,366.17 and the Dow Jones Industrial Average rising 0.8% to 51,654.95. Inovio Pharmaceuticals Inc. closed 57.7% short of its 52-week high of $2.72, which the company reached on December 17th. The stock outperformed some of its peers, as Johnson & Johnson rose 1.9% to $261.44, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.65% to $28.28. Trading volume totaled 2.5 million, compared to the 50-day average of 4.5 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 09, 2026 16:34 ET (20:34 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

US Treasury Secretary Besant: Will continue to seize Iran's cryptocurrency, no military conflict expected before the mid-term elections

ForesightNews•2026/10/11 13:23

A List of the 15 Altcoins Most Searched for in Recent Hours Has Been Published

BitcoinSistemi•2026/10/11 12:24

Michael Saylor releases bitcoin Tracker information again, possibly hinting at increasing BTC holdings

BlockBeats•2026/10/11 12:13

Crypto Pundit Says If You Are Holding XLM, Read This

TimesTabloid•2026/10/11 12:00